{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:29Z","timestamp":1707524369961},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,10]]},"DOI":"10.7759\/cureus.17880","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T22:04:05Z","timestamp":1631311445000},"source":"Crossref","is-referenced-by-count":0,"title":["Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department"],"prefix":"10.7759","author":[{"given":"Osman","family":"\u00d6cal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca","family":"Eldem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse H","family":"Karagoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadettin","family":"K\u0131l\u0131\u00e7kap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suayib","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhun","family":"Balkanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Peynircioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4968-3","article-title":"Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases","volume":"23","author":"Hughes MS","year":"2016","unstructured":"Hughes MS, Zager J, Faries M, et al.. Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol. 2016, 23:1309-19. 10.1245\/s10434-015-4968-3","journal-title":"Ann Surg Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-015-1276-z","article-title":"Percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies","volume":"39","author":"Burgmans MC","year":"2016","unstructured":"Burgmans MC, de Leede EM, Martini CH, Kapiteijn E, Vahrmeijer AL, van Erkel AR. Percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies. Cardiovasc Intervent Radiol. 2016, 39:801-14. 10.1007\/s00270-015-1276-z","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5729-z","article-title":"Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival","volume":"29","author":"Marquardt S","year":"2019","unstructured":"Marquardt S, Kirstein MM, Br\u00fcning R, et al.. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Eur Radiol. 2019, 29:1882-92. 10.1007\/s00330-018-5729-z","journal-title":"Eur Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303811","article-title":"Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study","volume":"1","author":"Curley SA","year":"1994","unstructured":"Curley SA, Newman RA, Dougherty TB, et al.. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol. 1994, 1:389-99. 10.1007\/BF02303811","journal-title":"Ann Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-013-0826-5","article-title":"Evaluation of Delcath Systems' Generation 2 (GEN 2) melphalan hemofiltration system in a porcine model of percutaneous hepatic perfusion","volume":"37","author":"Moeslein FM","year":"2014","unstructured":"Moeslein FM, McAndrew EG, Appling WM, et al.. Evaluation of Delcath Systems' Generation 2 (GEN 2) melphalan hemofiltration system in a porcine model of percutaneous hepatic perfusion. Cardiovasc Intervent Radiol. 2014, 37:763-9. 10.1007\/s00270-013-0826-5","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2723","article-title":"Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors","volume":"12","author":"Ravikumar TS","year":"1994","unstructured":"Ravikumar TS, Pizzorno G, Bodden W, et al.. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 1994, 12:2723-36. 10.1200\/JCO.1994.12.12.2723","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-012-0425-x","article-title":"Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma","volume":"35","author":"Deneve JL","year":"2012","unstructured":"Deneve JL, Choi J, Gonzalez RJ, et al.. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma. Cardiovasc Intervent Radiol. 2012, 35:1480-7. 10.1007\/s00270-012-0425-x","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23501","article-title":"Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience","volume":"109","author":"Forster MR","year":"2014","unstructured":"Forster MR, Rashid OM, Perez MC, Choi J, Chaudhry T, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience. J Surg Oncol. 2014, 109:434-9. 10.1002\/jso.23501","journal-title":"J Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2014.08.006","article-title":"Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan","volume":"14","author":"Hofmann H","year":"2014","unstructured":"Hofmann H, von Haken R, Werner J, et al.. Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan. Pancreatology. 2014, 14:546-9. 10.1016\/j.pan.2014.08.006","journal-title":"Pancreatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1366081","article-title":"Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers","volume":"186","author":"Vogl TJ","year":"2014","unstructured":"Vogl TJ, Zangos S, Scholtz JE, et al.. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers. Rofo. 2014, 186:937-44. 10.1055\/s-0034-1366081","journal-title":"Rofo"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000356","article-title":"Hepatic progression-free and overall survival after regional therapy to the liver for metastatic melanoma","volume":"41","author":"Abbott AM","year":"2018","unstructured":"Abbott AM, Doepker MP, Kim Y, et al.. Hepatic progression-free and overall survival after regional therapy to the liver for metastatic melanoma. Am J Clin Oncol. 2018, 41:747-53. 10.1097\/COC.0000000000000356","journal-title":"Am J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69768-initiation-of-chemosaturation-with-percutaneous-hepatic-perfusion-program-in-interventional-radiology-department","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:03Z","timestamp":1707507303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69768-initiation-of-chemosaturation-with-percutaneous-hepatic-perfusion-program-in-interventional-radiology-department"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.17880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}